[PHARMA] QoQ TTM Result on 31-Mar-2012 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
03-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 25.31%
YoY- 78.76%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 1,812,346 1,697,728 1,642,700 1,582,398 1,520,981 1,529,311 1,492,216 13.76%
PBT 103,314 115,434 102,587 94,349 73,186 54,117 53,876 54.04%
Tax -40,108 -32,578 -34,308 -28,102 -20,401 -15,466 -17,749 71.77%
NP 63,206 82,856 68,279 66,247 52,785 38,651 36,127 44.94%
-
NP to SH 61,711 81,587 67,151 65,358 52,157 37,959 35,734 43.70%
-
Tax Rate 38.82% 28.22% 33.44% 29.79% 27.88% 28.58% 32.94% -
Total Cost 1,749,140 1,614,872 1,574,421 1,516,151 1,468,196 1,490,660 1,456,089 12.94%
-
Net Worth 472,037 496,469 481,394 474,161 514,153 464,092 451,517 2.99%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 41,188 64,713 52,948 44,120 35,296 - - -
Div Payout % 66.74% 79.32% 78.85% 67.51% 67.67% - - -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 472,037 496,469 481,394 474,161 514,153 464,092 451,517 2.99%
NOSH 117,715 117,646 117,700 117,657 117,655 106,933 106,994 6.54%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 3.49% 4.88% 4.16% 4.19% 3.47% 2.53% 2.42% -
ROE 13.07% 16.43% 13.95% 13.78% 10.14% 8.18% 7.91% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 1,539.60 1,443.07 1,395.66 1,344.91 1,292.74 1,430.15 1,394.66 6.78%
EPS 52.42 69.35 57.05 55.55 44.33 35.50 33.40 34.86%
DPS 35.00 55.00 44.99 37.50 30.00 0.00 0.00 -
NAPS 4.01 4.22 4.09 4.03 4.37 4.34 4.22 -3.33%
Adjusted Per Share Value based on latest NOSH - 117,657
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 125.75 117.80 113.98 109.79 105.53 106.11 103.54 13.76%
EPS 4.28 5.66 4.66 4.53 3.62 2.63 2.48 43.64%
DPS 2.86 4.49 3.67 3.06 2.45 0.00 0.00 -
NAPS 0.3275 0.3445 0.334 0.329 0.3567 0.322 0.3133 2.98%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 8.10 7.55 10.18 5.90 5.36 5.90 5.90 -
P/RPS 0.53 0.52 0.73 0.44 0.41 0.41 0.42 16.69%
P/EPS 15.45 10.89 17.84 10.62 12.09 16.62 17.67 -8.52%
EY 6.47 9.19 5.60 9.42 8.27 6.02 5.66 9.28%
DY 4.32 7.28 4.42 6.36 5.60 0.00 0.00 -
P/NAPS 2.02 1.79 2.49 1.46 1.23 1.36 1.40 27.54%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 01/11/11 10/08/11 -
Price 7.80 8.25 8.83 5.90 5.90 5.90 5.90 -
P/RPS 0.51 0.57 0.63 0.44 0.46 0.41 0.42 13.75%
P/EPS 14.88 11.90 15.48 10.62 13.31 16.62 17.67 -10.77%
EY 6.72 8.41 6.46 9.42 7.51 6.02 5.66 12.06%
DY 4.49 6.67 5.09 6.36 5.08 0.00 0.00 -
P/NAPS 1.95 1.95 2.16 1.46 1.35 1.36 1.40 24.59%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment